The Keystone: Immune Cell Therapies: Advances in Cancer and Autoimmune Diseases will take place March 16-19, 2025 in Fairmont Banff Springs, Banff, AB, Canada.
Roman Galetto, Vice President, Preclinical and Program Management Director at Cellectis, will be presenting a poster as follows:
Date/Time: March 17, 2025 at 7:30 pm
Title: Preclinical efficacy of Multi-armored, TALEN® engineered Allogeneic MUC-1 CAR T-cells for the treatment of Triple-Negative Breast Cancer
Link to the conference: https://keysym.us/KSCellTherapy25
March 16, 2025
‐ February 19, 2025
Banff, Canada